French personal care ingredient maker Core Biogenesis and US skin care formulators YG Laboratories are teaming up to host a pro-longevity webinar on 9 December.
‘The Educator & The Innovator: Breaking New Ground in Skin Care Science, Beyond Retinol’ will feature YG Labs director of product development and education Rebecca Gadberry and Core Biogenesis chief commercial officer Tony Abboud.
Together, they will unveil breakthrough clinical data and the science behind the next generation of pro-longevity skin care powered by plant-based biomimetic growth factors.
The virtual event will offer unparalleled insight into how biotechnology is reshaping anti-aging performance, ingredient innovation, and formulation strategy for 2026 and beyond.
After four years of R&D, Core Biogenesis has developed the first Oleosome-fused human growth factors—Peauvita (Oleosome-EGF) and Peauforia (Oleosome-FGF-2)—designed to deliver rapid, measurable results without the drawbacks of retinol.
In just 14 days, these biomimetic actives deliver global improvements in wrinkles, smoothness, firmness, brightness, and barrier integrity—without irritation, instability, or preservation issues.
“With Peauvita and Peauforia, we’ve unlocked a faster, more effective, and sustainable alternative to retinol - plant-based biomimetic growth factors stabilized and delivered through oleosomes,” said Abboud (pictured, left).
Gadberry (pictured, right) added: “In my five decades in this industry, very few ingredients have delivered on their promises the way Peauvita and Peauforia do.
“After just ten days of using the Oleosome-Growth factors, I saw a transformation in my own skin that I haven't experienced with anything else.”
The free webinar takes place on 9am PST/12pm EST/6pm CET on Tuesday 9 December.
The session includes: full clinical data reveal; technical analysis + personal results; before-and-after imagery; ingredient science deep dive; live Q&A; and exclusive follow-up educational materials for registered attendees.
Registration can be found at https://my.demio.com/ref/QLoC7w0MS8hSGRIO.
